BioTherapeutics | 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060

Publications

Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes.

Lu P, Hontecillas R, Philipson CW, Bassaganya-Riera J.
Curr Drug Targets 2014 Jun 1;15(6):565-72

Back to top